Calendar

Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.

Upcoming as of , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.

8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.

Add to your calendar (calendar.ics)

The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.

Upcoming

June 2029 65

  1. Study completion DICE Study- Diastolic Improvement With Carvedilol & Empagliflozin in Patients With Cirrhosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07322237

  2. Study completion Safety and Efficacy of De-escalation Dual Antiplatelet Therapy After BioFreedom™ Stenting in ACS Patients With Moderate-to-high Ischemic and High Bleeding Risk Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07374718

  3. Study completion Head Cooling in Ischaemic Stroke Patients Undergoing Endovascular Thrombectomy (COOLHEAD-2b) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07526649

  4. Primary completion Oropharyngeal Flushing Suction Tube With Laryngoscope for Stroke-Associated Pneumonia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07647666

  5. Study completion APEX-STROKE CALM-ICH Domain Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07752719

  6. Study completion Motor Cortex Stimulation for Post-Stroke Thalamic Pain Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07758829

  7. Study completion Intravenous Recombinant Human Prourokinase for Acute Medium Vessel Occlusion 4.5-24 Hours After Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07776873

  8. Primary completion Intravenous Recombinant Human Prourokinase for Acute Medium Vessel Occlusion 4.5-24 Hours After Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07776873

  9. Primary completion APEX-STROKE Adaptive Platform Trial for Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07784569

  10. Primary completion APEX-STROKE EAGLE Domain (EAGLE) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07790354

  11. Primary completion The Variation in Electrode Configuration for Termination of Out-of-Hospital Rhythms That Are Shockable in Cardiac Arrest Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07818785

  12. Study completion Prevention of Ischemic Stroke Recurrence Using Digital Technology Application Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07825311

  13. Study completion Long-Term Sequential Dual Antiplatelet Therapy Based on Cilostazol in Symptomatic Intracranial Arterial Stenosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07932639

July 2029 38

  1. Study completion Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06082063

  2. Primary completion Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06082063

  3. Primary completion Response to Exercise and Nitric Oxide in PAD Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06657976

  4. Study completion Intra-Arterial Thrombolysis After SUCCESSful Reperfusion in Anterior Circulation Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06768138

  5. Study completion StAtins in Frail OldEr Patients with Ischemic Stroke or Transient Ischemic Attack - the Randomized Controlled Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06785727

  6. Primary completion BEACON-AA: Apixaban With or Without Clopidogrel in Stroke Patients With Atrial Fibrillation and Cerebral Atherosclerosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07237308

  7. Study completion Apixaban Versus Warfarin for Left Ventricular Thrombus Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07709780

  8. Study completion The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03614260

  9. Study completion Epinephrine Versus Isoprenaline During Out-of-Hospital Cardiac Arrest With Asystole Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06473116

  10. Primary completion Epinephrine Versus Isoprenaline During Out-of-Hospital Cardiac Arrest With Asystole Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06473116

  11. Study completion CGM for Management of Type 2 Diabetes in Pregnancy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06628453

  12. Primary completion A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07285655

  13. Primary completion Dual Antiplatelet Therapy Strategies After Acute Myocardial Infarction Undergoing PCI: Prasugrel vs Ticagrelor & 12 Months vs 1-3 Months Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07507500

  14. Primary completion Advancing Clinical Heart Failure Outcomes Leveraging Defibrillation Lead Implant System for Left Bundle Branch Area Pacing Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07526896

  15. Primary completion Intravenous Iron to Improve Symptoms, Quality of Life and Exercise Capacity in HFpEF With Iron Deficiency Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07643818

  16. Study completion Mazdutide for Adults With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled Trial (DREAM-PRE) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07654062

  17. Primary completion A Study of Bimagrumab in Participants With HFpEF Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07920887

  18. Study completion Low-Dose Versus Standard-Dose Tenecteplase for Acute Minor Ischemic Stroke With Disabling Deficits Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07944261

  19. Study completion Safety and Efficacy of the HighLife Transcatherter Mitral Valve Replacement System in Patients With Moderate-severe or Severe Mitral Regurgitation in China Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05610566

  20. Primary completion A Study to Evaluate the Safety and Efficacy of Mavacamten in Adults With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy (SOLSTICE-HCM) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07940777

  21. Primary completion A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07567001

  22. Primary completion Surveillance of Pancreatic Health After Diabetes Diagnosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06803771

  23. Primary completion Spatiotemporal Evolution of Traditional Chinese Medicine Mechanisms in Acute Ischemic Stroke Treated With Dengzhan Xixin and Dengzhan Shengmai Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07591883

  24. Primary completion Aspirin-Free Strategy After 3-6 Month Dual Antiplatelet Therapy in Acute Coronary Syndrome Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07736196

  25. Study completion The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05836987

  26. Primary completion The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05836987

  27. Study completion Safety and Effectiveness of TaurusTrio™ Heart Valve System in Patients With Severe Aortic Regurgitation (AR) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06101888

  28. Primary completion FLudrocortisone Administration in Aneurysmal Subarachnoid Haemorrhage Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06409364

  29. Primary completion Genotype-Guided Abbreviated DAPT Versus Un-Guided De-escalation Therapy in Patients With ACS and HBR Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06763744

  30. Primary completion CiLostAzol for pReventIon of Recurrent sTroke in Africa Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06919835

  31. Study completion Early Statin-Ezetimibe Combination vs. Statin Monotherapy in Stroke With Atherosclerosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07307989

  32. Primary completion Early Statin-Ezetimibe Combination vs. Statin Monotherapy in Stroke With Atherosclerosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07307989

  33. Study completion Spatiotemporal Evolution of Traditional Chinese Medicine Mechanisms in Acute Ischemic Stroke Treated With Dengzhan Xixin and Dengzhan Shengmai Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07591883

  34. Study completion Oropharyngeal Flushing Suction Tube With Laryngoscope for Stroke-Associated Pneumonia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07647666

August 2029 33

  1. Study completion Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05491200

  2. Study completion Mazdutide in Type 2 Diabetes With Early-Stage Cognitive Impairment (LIGHT-COG Study) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07083154

  3. Primary completion Mazdutide in Type 2 Diabetes With Early-Stage Cognitive Impairment (LIGHT-COG Study) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07083154

  4. Study completion Anti-atherosclerotic Efficacy of Selected Antidiabetic Drugs in Patients With Coronary Artery Disease and Pre-diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07254572

  5. Primary completion Anti-atherosclerotic Efficacy of Selected Antidiabetic Drugs in Patients With Coronary Artery Disease and Pre-diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07254572

  6. Study completion Remote Monitoring and Optimization of Heart Failure Therapy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07622472

  7. Primary completion Tirzepatide on Atrial Fibrillation Recurrence After Catheter Ablation in Patients With Obesity and HFpEF Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07630454

  8. Study completion Tenecteplase or Reteplase as Bridging Thrombolysis Before Thrombectomy in Acute Ischemic Cerebrovascular Events Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07748039

  9. Primary completion Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO-EU Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05496998

  10. Study completion An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05667493

  11. Primary completion An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05667493

  12. Study completion BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06059638

  13. Primary completion SWITCH: Apixaban vs Vitamin K in HM3 Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07471139

  14. Primary completion Normal Saline Infusion After Intravenous Thrombolysis in Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07497542

  15. Primary completion Regression in Left Ventricular Hypertrophy and Fibrosis in Aortic Stenosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07539259

  16. Study completion Coronary Artery Stents in Heart Failure With Preserved Ejection Fraction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07560436

  17. Primary completion NORM-HF Pivotal Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07574593

  18. Study completion Early Prophylactic Aspirin for Aneurysmal Subarachnoid Hemorrhage Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07642427

  19. Primary completion A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07794579

  20. Study completion A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07567001

  21. Primary completion Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07318610

  22. Study completion Left Bundle Branch Area Pacing Versus Right Ventricular Pacing in Atrioventricular Block With Preserved Ejection Fraction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07464041

  23. Primary completion Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05714085

  24. Study completion Digoxin and Senolysis in Heart Failure and Diabetes Mellitus Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06240403

  25. Primary completion Pediatric Prehospital Airway Resuscitation Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06364280

  26. Primary completion Comparison of Pitavastatin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06767774

  27. Study completion CiLostAzol for pReventIon of Recurrent sTroke in Africa Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06919835

  28. Study completion Stepped-Wedge Cluster Randomized Trial of AI-Assisted CTA Detection for Intracranial Aneurysms in Regional Hospitals Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07124624

  29. Study completion BEACON-AA: Apixaban With or Without Clopidogrel in Stroke Patients With Atrial Fibrillation and Cerebral Atherosclerosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07237308

  30. Study completion A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07816185

  31. Primary completion CATCH AF - Atrial Fibrillation Detection in Cryptogenic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07899788

September 2029 50

  1. Study completion Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03264352

  2. Primary completion The Fourth Left Atrial Appendage Occlusion Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05963698

  3. Primary completion Effect of Add-on SGLT2i, TZD, or Combination Therapy in Type 2 Diabetes Patients on DPP4 Inhibitors Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07108985

  4. Primary completion Effect of Tirzepatide on Recurrence of Atrial Fibrillation After Catheter Ablation in Obese Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07715929

  5. Study completion Normobaric Hyperoxia With Extended-Window Endovascular Therapy for Acute Ischemic Stroke (OPENS-EXTEND) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07717216

  6. Primary completion Normobaric Hyperoxia With Extended-Window Endovascular Therapy for Acute Ischemic Stroke (OPENS-EXTEND) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07717216

  7. Study completion Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors With Statin for ACS Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07736313

  8. Study completion Ablation With Transcatheter Edge-to-edge Repair for Atrial Functional Mitral Regurgitation and Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07744035

  9. Study completion ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03735667

  10. Study completion MumCare: Mum's Cardiovascular Health for Life Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05835596

  11. Primary completion MumCare: Mum's Cardiovascular Health for Life Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05835596

  12. Primary completion ATLAS (AltaValve) Pivotal Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06465745

  13. Primary completion Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06526195

  14. Study completion Study EHR Risk Stratification Tools Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06995378

  15. Primary completion Epicardial Adipose Tissue Composition and Heart Failure With Preserved Ejection Fraction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07178145

Overdue

The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.

  1. Primary completion Peri-treatment of SGLT-2 Inhibitor on Myocardial Infarct Size and Remodeling Index in Patients With Acute Myocardial Infarction and High Risk of Heart Failure Undergoing Percutaneous Coronary Intervention Registry record

    Expected 2025-08-31; that period ended on 2025-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04899479

  2. Study completion Low Dose Prasugrel vs Clopidogrel for Stenting or Flow Diverter for Unruptured Aneurysm Registry record

    Expected 2025-08; that period ended on 2025-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05359224

  3. Study completion The Left Bundle Cardiac Resynchronization Therapy Trial Registry record

    Expected 2025-08-31; that period ended on 2025-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05434962

  4. Study start Shock Energy for Electrical Cardioversion of Persistent Atrial Fibrillation Registry record

    Expected 2025-08; that period ended on 2025-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05903170

  5. Study completion All Women Comparing Self-expanding ALLEGRA Valve to Any Other Balloon-expandable Valve Registry record

    Expected 2025-08-31; that period ended on 2025-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05989074

  6. Primary completion All Women Comparing Self-expanding ALLEGRA Valve to Any Other Balloon-expandable Valve Registry record

    Expected 2025-08-31; that period ended on 2025-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05989074

  7. Study completion Intravenous TNK vs TPA for AIS Treatment on MSU,a Prospective Multicenter RCT Registry record

    Expected 2025-08-31; that period ended on 2025-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06498323

  8. Primary completion Intravenous TNK vs TPA for AIS Treatment on MSU,a Prospective Multicenter RCT Registry record

    Expected 2025-08-31; that period ended on 2025-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06498323

  9. Study completion Short Term Reproducibility of Office White-coat Effect Registry record

    Expected 2025-08-31; that period ended on 2025-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06523062

  10. Primary completion Short Term Reproducibility of Office White-coat Effect Registry record

    Expected 2025-08-31; that period ended on 2025-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06523062

  11. Study start Transcutaneous Electrical Acupoint Stimulation on Blood Pressure Registry record

    Expected 2025-08; that period ended on 2025-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06537167

  12. Primary completion Impact of Enhanced Information on Subjective Information Level and PROMs in Patients with Aortic Stenosis Registry record

    Expected 2025-08; that period ended on 2025-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06706635

  13. Study completion Efficacy of Remote Monitoring of Patients With Heart Failure and Reduced Ejection Fraction by Using Caaring® Software Registry record

    Expected 2025-08; that period ended on 2025-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06920160

  14. Study completion EVOLVING AZIMUTH IN MUSA CONTEXT Registry record

    Expected 2025-08-31; that period ended on 2025-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07022067

  15. Study completion Safety and Efficacy Study of the First Domestically Produced FireMagic™ PreciSense™ 3D Microelectrode Ablation Catheter Therapy for Rapid Arrhythmia With Tissue Temperature Measurement Function Registry record

    Expected 2025-08-31; that period ended on 2025-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07032948

  16. Primary completion Safety and Efficacy Study of the First Domestically Produced FireMagic™ PreciSense™ 3D Microelectrode Ablation Catheter Therapy for Rapid Arrhythmia With Tissue Temperature Measurement Function Registry record

    Expected 2025-08-31; that period ended on 2025-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07032948

  17. Study start Safety and Efficacy Study of the First Domestically Produced FireMagic™ PreciSense™ 3D Microelectrode Ablation Catheter Therapy for Rapid Arrhythmia With Tissue Temperature Measurement Function Registry record

    Expected 2025-08-31; that period ended on 2025-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07032948

  18. Study start Traditional Chinese Medicine Intervention for Ischemic Cerebrovascular Disease and Diabetes Mellitus: An Efficacy Comparative Study Registry record

    Expected 2025-08-31; that period ended on 2025-08-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07121088

  19. Study completion Randomized Trial Comparing Two Sirolimus-Eluting Stents in Diabetes Mellitus Registry record

    Expected 2025-09-01; that period ended on 2025-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04660240

  20. Study completion NanO2 for Large Vessel Occlusion Stroke Registry record

    Expected 2025-09-01; that period ended on 2025-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05389748

  21. Primary completion Antazoline in Comparison to Propafenone in Pharmacological Cardioversion of Atrial Fibrillation. Registry record

    Expected 2025-09-01; that period ended on 2025-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05720572

  22. Primary completion Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study Registry record

    Expected 2025-09-01; that period ended on 2025-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05868239

  23. Study completion Persistent Atrial Fibrillation Without the Evidence of Low-voltage Areas Registry record

    Expected 2025-09-01; that period ended on 2025-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06124690

  24. Primary completion Persistent Atrial Fibrillation Without the Evidence of Low-voltage Areas Registry record

    Expected 2025-09-01; that period ended on 2025-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06124690

  25. Study start Digoxin and Senolysis in Heart Failure and Diabetes Mellitus Registry record

    Expected 2025-09-01; that period ended on 2025-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06240403

  26. Study completion The Effects of CGM and Connected Pen in T2DM Treated With Multiple Daily Insulin Injections Registry record

    Expected 2025-09-01; that period ended on 2025-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06311019

  27. Study start Evaluation of the InterFACE-AR System for Cardiopulmonary Arrest Registry record

    Expected 2025-09-01; that period ended on 2025-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06411327

  28. Study start Telerehabilitation of Balance Clinical and Economic Decision Support System Registry record

    Expected 2025-09-01; that period ended on 2025-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06534164

  29. Study start Microvascular Obstruction Diagnosis Using the CoFI™ System Assessment - II Registry record

    Expected 2025-09-01; that period ended on 2025-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06909578

  30. Study start Pre-emptive Coil Embolization in Endovascular Aortic Repair Registry record

    Expected 2025-09-01; that period ended on 2025-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06975215

  31. Primary completion The Effect of Low-Level Tragus Stimulation on Echocardiographic Parameters in Patients With ST-Segment Elevation Myocardial Infarction - A Single-Centre Randomized Control Trial Registry record

    Expected 2025-09-01; that period ended on 2025-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07058857

  32. Study start Tenecteplase in ReperfUsion Therapy for Posterior Circulation Stroke With Extended Time Window: the TRUST Trial Registry record

    Expected 2025-09-01; that period ended on 2025-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07073469

  33. Study start Phrenic Nerve Stimulation for Reducing Ventilation Duration in Acute Cerebral Infarction: A Multicenter Randomized Controlled Trial Registry record

    Expected 2025-09-01; that period ended on 2025-09-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07133932

  34. Study start The Study of Efficacy and Safety of Dimephosphon® in Acute Ischemic Stroke Registry record

    Expected 2025-09-06; that period ended on 2025-09-06.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07167550

  35. Primary completion Combining Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Large-vessel Ischemic Stroke Registry record

    Expected 2025-09-10; that period ended on 2025-09-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06360120

  36. Primary completion Olive Leaf Extracts in the Control of Diabet Registry record

    Expected 2025-09-15; that period ended on 2025-09-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05605704

  37. Primary completion Combining Aspirin With Ticagrelor or Clopidogrel in Large-vessel Minor Stroke or TIA Registry record

    Expected 2025-09-15; that period ended on 2025-09-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06591338

  38. Study start Inhaled Isoflurane for Sedation of Invasively Ventilated Patients With Cardiogenic Shock on Extracorporeal Membrane Oxygenation Registry record

    Expected 2025-09-15; that period ended on 2025-09-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07099014

  39. Study start Smart Technologies in Early Post-Stroke Rehabilitation Registry record

    Expected 2025-09-15; that period ended on 2025-09-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07171073

  40. Study start PCSK9 Inhibitors in Acute Ischemic Stroke Patients Undergoing Endovascular Therapy Registry record

    Expected 2025-09-15; that period ended on 2025-09-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07174375

  41. Primary completion Combining Aspirin With Ticagrelor or Cilostazol in Large-vessel Minor Stroke or TIA Registry record

    Expected 2025-09-19; that period ended on 2025-09-19.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06591377

  42. Study start Prevention of Stroke Recurrence and Disease Progression in Cerebral Small Vessel Disease With Cilostazol Registry record

    Expected 2025-09-20; that period ended on 2025-09-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07180472

  43. Study start ACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney Diseases Registry record

    Expected 2025-09-20; that period ended on 2025-09-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07187713

  44. Study completion Evaluate the Safety and Efficacy of Intracoronary Lithotripsy Balloon Catheter and Intracoronary Lithotripsy Apparatus Registry record

    Expected 2025-09-22; that period ended on 2025-09-22.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05649488

  45. Study completion The Effects of Early and Late Injection of Botulinum Toxin Type A on Upper Limb Function in Patients With Stroke Registry record

    Expected 2025-09; that period ended on 2025-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02580838

  46. Primary completion For Patients With Ischemic Stroke, Clinically Study the Effectiveness and Safety of Butylphthalide. Registry record

    Expected 2025-09; that period ended on 2025-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05068349

  47. Study completion Enhance Study: Evaluation of Accuracy and Safety of the Eversense CGM System With Enhanced Features Registry record

    Expected 2025-09-30; that period ended on 2025-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05131139

  48. Primary completion The Impact of Electroacupuncture Combined With NGF on Clinical Effect and Functional Changes on Ischemic Stroke Registry record

    Expected 2025-09-30; that period ended on 2025-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05231694

  49. Study completion Cardiac Resynchronization Therapy Delivery Guided Non-Invasive Electrical and Venous Anatomy Assessment Registry record

    Expected 2025-09; that period ended on 2025-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05327062

  50. Study completion Low-Dose Dobutamine and Single-Dose Tocilizumab in Acute Myocardial Infarction With High Risk of Cardiogenic Shock Registry record

    Expected 2025-09-30; that period ended on 2025-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05350592

  51. Primary completion Acute Subcutaneous SemaglutidE in Acute Ischemic sTroke Registry record

    Expected 2025-09; that period ended on 2025-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05630586

  52. Primary completion DIrect Oral Anticoagulation and Bioprothesis Aortic Valve Registry record

    Expected 2025-09; that period ended on 2025-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05687448

  53. Study start DIrect Oral Anticoagulation and Bioprothesis Aortic Valve Registry record

    Expected 2025-09; that period ended on 2025-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05687448

  54. Study completion Treatment of Chronic Post-stroke Oropharyngeal Dysphagia With Paired Stimulation Registry record

    Expected 2025-09; that period ended on 2025-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05720871

  55. Study completion Dutogliptin in Co-administration With Filgrastim in Early Recovery Post-myocardial Infarction Registry record

    Expected 2025-09; that period ended on 2025-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05881382

  56. Primary completion Dutogliptin in Co-administration With Filgrastim in Early Recovery Post-myocardial Infarction Registry record

    Expected 2025-09; that period ended on 2025-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05881382

  57. Primary completion MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions Registry record

    Expected 2025-09; that period ended on 2025-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05908331

  58. Study start Narrative Intervention for Chronic Illness- Heart Failure Trial (NICI-HF) Registry record

    Expected 2025-09; that period ended on 2025-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06097481

  59. Primary completion A Trial to Investigate the Efficacy and Safety of NW Low-Glu® in Patients With Type II Diabetes Mellitus Registry record

    Expected 2025-09; that period ended on 2025-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06140485

  60. Study completion Study to Evaluate the Long Term Safety and Efficacy of DWP16001 in Patients With Type 2 Diabetes Mellitus Registry record

    Expected 2025-09; that period ended on 2025-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06141980

  61. Primary completion Study to Evaluate the Long Term Safety and Efficacy of DWP16001 in Patients With Type 2 Diabetes Mellitus Registry record

    Expected 2025-09; that period ended on 2025-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06141980

  62. Study completion BXOS110 Injection in the Treatment of Acute Ischaemic Stroke Registry record

    Expected 2025-09; that period ended on 2025-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06322394

  63. Study start Modafinil and Exercise for Post Stroke Fatigue Registry record

    Expected 2025-09; that period ended on 2025-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06354985

  64. Study completion A Study to Evaluate the Efficacy and Safety of Co-administration of AD-227A and AD-227B Registry record

    Expected 2025-09; that period ended on 2025-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06441630

  65. Primary completion A Study to Evaluate the Efficacy and Safety of Co-administration of AD-227A and AD-227B Registry record

    Expected 2025-09; that period ended on 2025-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06441630

  66. Primary completion The Androtriol Injection for the Treatment of Acute Ischemic Stroke Registry record

    Expected 2025-09-30; that period ended on 2025-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06679322

  67. Primary completion CAP-TEER: CerebrAl Protection During Transcatheter Edge-to-edge Repair Registry record

    Expected 2025-09-30; that period ended on 2025-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06814210

  68. Study start Randomised EValuation of Therapies for microvAscuLar Injury in STEACS Registry record

    Expected 2025-09; that period ended on 2025-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06935383

  69. Study completion Use of Three-Dimensional Printed Models for Endovascular Planning and Follow-up in Patients Affected by Aorto-Iliac-Femoral-Popliteal Arterial Disease Undergoing Balloon Angioplasty. A Single-center, Single-blind Randomized Controlled Trial Registry record

    Expected 2025-09-30; that period ended on 2025-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07000097

  70. Study completion The Effect of Low-Level Tragus Stimulation on Echocardiographic Parameters in Patients With ST-Segment Elevation Myocardial Infarction - A Single-Centre Randomized Control Trial Registry record

    Expected 2025-09-30; that period ended on 2025-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07058857

  71. Study start Effect of Add-on SGLT2i, TZD, or Combination Therapy in Type 2 Diabetes Patients on DPP4 Inhibitors Registry record

    Expected 2025-09; that period ended on 2025-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07108985

  72. Study start The Clinical Application of Peripheral Embolization Coil Systems in Arteriovenous Embolization Within the Peripheral Vasculature Registry record

    Expected 2025-09; that period ended on 2025-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07156409

  73. Study start A Phase 3 Study of HS-20094 in Patients With T2DM Inadequately Controlled With Diet and Exercise Alone Registry record

    Expected 2025-09-30; that period ended on 2025-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07156500

  74. Study start A Phase 3 Study of HS-20094 in Patients With T2DM Registry record

    Expected 2025-09-30; that period ended on 2025-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07156539

  75. Study start REMIssion of Type 2 Diabetes Between Intermittently Scanned Continuous Glucose Monitoring and Capillary Blood Glucose Monitoring When Added to Low-calorie Meal Replacement and Diabetes Self-management Education Registry record

    Expected 2025-09; that period ended on 2025-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07157384

  76. Study start Clinical validatiOn of an AI-based DEcision Support System for Robotic Upper Limb Rehabilitation in Patients With Stroke. A CO-AIDER Study. Registry record

    Expected 2025-09; that period ended on 2025-09-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07199322

  77. Study completion Safety and Efficacy of the CGuard™ Carotid Stent System in Carotid Artery Stenting Registry record

    Expected 2025-10-01; that period ended on 2025-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04900844

  78. Study completion Evaluation of Safety and Effectiveness of the EMBLOK EPS During TAVR Registry record

    Expected 2025-10-01; that period ended on 2025-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05295628

  79. Study completion Evaluation of Safety and Effectiveness of Lobster Dynamic Interspinous Spacer in Lumbar Spinal Stenosis Registry record

    Expected 2025-10-01; that period ended on 2025-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05587465

  80. Study completion Effect of Azilsartan on Atrial Fibrillation in Patients With Hypertension Registry record

    Expected 2025-10-01; that period ended on 2025-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05841654

  81. Study completion Mobile Cardiac Outpatient Telemetry for Unexplained Syncope Registry record

    Expected 2025-10-01; that period ended on 2025-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05957315

  82. Primary completion Mobile Cardiac Outpatient Telemetry for Unexplained Syncope Registry record

    Expected 2025-10-01; that period ended on 2025-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05957315

  83. Study completion Effect of Menopause Hormone Therapy In Postmenopausal Women With CSVD And MCI Registry record

    Expected 2025-10-01; that period ended on 2025-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05982470

  84. Primary completion Effect of Spironolactone in the Prevention of Anthracycline-induced Cardiotoxicity (SPIROTOX) Registry record

    Expected 2025-10-01; that period ended on 2025-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06005259

  85. Primary completion REBOA in Nontraumatic OHCA Registry record

    Expected 2025-10-01; that period ended on 2025-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06031623

  86. Primary completion The Man Van Project Registry record

    Expected 2025-10-01; that period ended on 2025-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06357416

  87. Study completion Combining Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Large-vessel Ischemic Stroke Registry record

    Expected 2025-10-01; that period ended on 2025-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06360120

  88. Study completion Combining Aspirin With Ticagrelor or Cilostazol in Large-vessel Minor Stroke or TIA Registry record

    Expected 2025-10-01; that period ended on 2025-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06591377

  89. Primary completion Clinical Study on the Intervention of Xuesaitong Soft Capsules in Post-Intervention Patients with Acute Coronary Syndrome and Clinical Research Protocol Registry record

    Expected 2025-10-01; that period ended on 2025-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06845254

  90. Study start CorVad Myocardial Infarction Complicated with Cardiogenic Shock Trial Registry record

    Expected 2025-10-01; that period ended on 2025-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06886113

  91. Study start TENS for Limb Function in Stroke: Design and Rationale for a Randomized Trial Registry record

    Expected 2025-10-01; that period ended on 2025-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06997744

  92. Study start Perioperative Intensive Statin Therapy for Neuroprotection in TAVR(PISTNT) Registry record

    Expected 2025-10-01; that period ended on 2025-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07087379

  93. Study start Atrial Fibrillation: In Search for the Optimal Target for Rate Control Registry record

    Expected 2025-10-01; that period ended on 2025-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07135258

  94. Study start A Study Evaluating the Effectiveness and Safety of Pulsed Field Ablation Using the FARAPULSE™ System for Electrical Isolation of Pulmonary Veins and Superior Vena Cava Registry record

    Expected 2025-10-01; that period ended on 2025-10-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07162597

  95. Primary completion Efficacy and Safety of SPC1001 in Patients With Essential Hypertension Registry record

    Expected 2025-10-08; that period ended on 2025-10-08.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06826872

  96. Study start Stepped-Wedge Cluster Randomized Trial of AI-Assisted CTA Detection for Intracranial Aneurysms in Regional Hospitals Registry record

    Expected 2025-10-09; that period ended on 2025-10-09.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07124624

  97. Study completion Efficacy of Oral Acetazolamide in Decongestion in Patients With Heart Failure Registry record

    Expected 2025-10-10; that period ended on 2025-10-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05940220

  98. Study completion Combining Aspirin With Ticagrelor or Clopidogrel in Large-vessel Minor Stroke or TIA Registry record

    Expected 2025-10-10; that period ended on 2025-10-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06591338

  99. Study start A Multicenter, Randomized, Double-blind, Placebo-controlled Trial on the Treatment of Hypertensive Intracerebral Hemorrhage With Naoxuekang Dropping Pills Registry record

    Expected 2025-10-10; that period ended on 2025-10-10.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07200921

  100. Primary completion COSIMA: COronary SInus Reducer for the Treatment of Refractory Microvascular Angina Registry record

    Expected 2025-10-20; that period ended on 2025-10-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04606459